Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Jumbo adds MS, subtracts margins
Health & Biotech
Brain health is complicated, but these ASX small caps are trying to keep it in shape
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
Health: Invion may have found its break in Chinese dermatology
Health & Biotech
Health: Gut treatment progress gives Anatara a 24pc boost
Health & Biotech
Health: Is this the big news from Germany Pharmaxis was waiting for?
Health & Biotech
Biotech exec pay — are they delivering returns that equal their pay packets?
Escrow Watch
Escrow Watch: 300 million shares are marching onto the ASX this fortnight
Health & Biotech
Health: Bionomics looks to get ‘back on track’ as it switches into the fast lane for US approval
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
